|26.44||-0.6000||-2.22%||Vol 4.35K||1Y Perf 98.37%|
|Apr 19th, 2021 10:22 DELAYED|
|- -%||- -|
|Target Price||32.00||Analyst Rating||Moderate Buy 2.00|
|Potential %||20.39||Finscreener Ranking||★★★★+ 56.64|
|Insiders Trans % 3/6/12 mo.||-/-/38||Value Ranking||★★★★ 56.88|
|Insiders Value % 3/6/12 mo.||-/-/-2||Growth Ranking||★★★★+ 63.22|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-2||Income Ranking||— -|
|Market Cap||1.44B||Earnings Rating||Neutral|
|Price Range Ratio 52W %||87.50||Earnings Date||26th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|10 Years||1 081.82%|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||26th May 2021|
|Estimated EPS Next Report||0.22|
|EPS Growth Next 5 Years %||5.00|
|Avg. Weekly Volume||33.64K|
|Avg. Monthly Volume||49.53K|
|Avg. Quarterly Volume||63.56K|
Apollo Medical Holdings Inc. (NASDAQ: AMEH) stock closed at 27.04 per share at the end of the most recent trading day (a -0.33% change compared to the prior day closing price) with a volume of 23.35K shares and market capitalization of 1.44B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 555 people. Apollo Medical Holdings Inc. CEO is Kenneth Sim / Thomas S. Lam.
The one-year performance of Apollo Medical Holdings Inc. stock is 98.37%, while year-to-date (YTD) performance is 48%. AMEH stock has a five-year performance of 350.67%. Its 52-week range is between 13.21 and 28.33, which gives AMEH stock a 52-week price range ratio of 87.50%
Apollo Medical Holdings Inc. currently has a PE ratio of 26.40, a price-to-book (PB) ratio of 3.57, a price-to-sale (PS) ratio of 2.27, a price to cashflow ratio of 21.70, a PEG ratio of 2.32, a ROA of 4.70%, a ROC of 8.63% and a ROE of 14.04%. The company’s profit margin is 23.77%, its EBITDA margin is 30.20%, and its revenue ttm is $518.33 Million , which makes it $11.73 revenue per share.
Of the last four earnings reports from Apollo Medical Holdings Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.22 for the next earnings report. Apollo Medical Holdings Inc.’s next earnings report date is 26th May 2021.
The consensus rating of Wall Street analysts for Apollo Medical Holdings Inc. is Moderate Buy (2), with a target price of $32, which is +20.39% compared to the current price. The earnings rating for Apollo Medical Holdings Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Apollo Medical Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Apollo Medical Holdings Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.20, ATR14 : 0.86, CCI20 : 25.09, Chaikin Money Flow : 0.10, MACD : 1.01, Money Flow Index : 61.36, ROC : 1.05, RSI : 60.67, STOCH (14,3) : 42.67, STOCH RSI : 0.73, UO : 57.92, Williams %R : -57.33), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Apollo Medical Holdings Inc. in the last 12-months were: Adrian Vazquez (Sold 86 005 shares of value $1 496 356 ), Albert Young (Sold 0 shares of value $-490 961 ), Brandon Sim (Buy at a value of $749 544), Eric Chin (Buy at a value of $60 792), Kenneth Sim (Buy at a value of $371 072), Kenneth Sim (Sold 0 shares of value $-889 168 ), Mark Fawcett (Option Excercise at a value of $200 000), Thomas S. Lam (Buy at a value of $266 781), Thomas S. Lam (Sold 0 shares of value $-889 140 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.